Robert brings to Fluent BioSciences over a decade of biomedical engineering and molecular biophysics experience in the development of advanced genomic-analysis technologies for applications in infectious disease, food safety, and cancer diagnostics. Specifically, he shepherds from ideation to implementation of novel technologies that integrate fluorescence detection, microfluidic systems, and sound molecular biochemistry. He served as a staff scientist at US Genomics and then as a senior scientist when that company became Pathogenetix. At Bio-Rad, Robert managed the microfluidics team.
Robert earned a BS from Texas A&M University, Ph.D. from Baylor College of Medicine, and completed his postdoctoral work at University of Alabama, Birmingham.